Q2 2026 saw 20% revenue growth, strong European performance, and strategic milestones like UK MoD approval and new product launches. U.S. order delays impacted intake but are expected to recover in H2. Gross margin declined due to a large radio order delivery.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.